CT
DXCM icon

Clearstead Trust’s DexCom DXCM Stock Holding History

Clearstead Trust’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7K Sell
104
-9
-8% -$600 ﹤0.01% 702
2026
Q1 		$7.1K Buy
113
+9
+9% +$627 ﹤0.01% 673
2025
Q4 		$6.9K Buy
104
+62
+148% +$4.01K ﹤0.01% 684
2025
Q3 		$2.83K Buy
42
+3
+8% +$237 ﹤0.01% 896
2025
Q2 		$3.4K Buy
+39
New +$3.06K ﹤0.01% 825

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clearstead Trust's DXCM Position: Q2 2026 in Review

Clearstead Trust reduced its DexCom (DXCM) stake by 8% in Q2 2026, selling an estimated $600 and leaving 104 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #702.

Clearstead Trust first reported a position in DXCM in Q2 2025 and has held it in 5 quarters since. The position peaked at $7.1K in Q1 2026. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Clearstead Trust held 104 shares of DexCom worth $7K as of Q2 2026.
  • Clearstead Trust sold 9 DexCom shares in Q2 2026, an estimated $600.
  • DexCom made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #702 holding.
  • Clearstead Trust first reported a position in DexCom in Q2 2025 and has held it in 5 quarters since.
  • Clearstead Trust's DexCom position peaked at $7.1K in Q1 2026.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.